Pieris Pharmaceuticals Inc (NASDAQ:PIRS) traded at $0.22 at close of the session on Tuesday, March 19, made an upward move of 2.62% on its previous day’s price.
Looking at the stock we see that its previous close was $0.21 and the beta (5Y monthly) reads 0.47 . In terms of its 52-week price range, PIRS has a high of $1.52 and a low of $0.14. The company’s stock has gained about 37.96% over that past 30 days.
Pieris Pharmaceuticals Inc has a market cap of $21.30 million and is expected to release its quarterly earnings report on Mar 27, 2024 – Apr 01, 2024.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $2.24 million, with a low of $2.24 million and a high of $2.24 million. The median projection represents growth adding up to -61.70% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2023 is expected to hit $31.98 million, or 23.50% up from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the PIRS stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is 25.58% off its SMA20 and 26.78% from its 50-day simple moving average. The RSI (14) is pointing at 71.98 while the volatility over the past week is 21.48% and jumps to 11.26% over the past one month. The beta value is 0.46, while the average true range (ATR) is currently pointing at 0.02.
Coming back to Pieris Pharmaceuticals Inc (NASDAQ:PIRS), we note that the average 3-month trading volume was 538.17K, while that of the preceding 10-day period stands at 1.38 million. Current shares outstanding are 98.85 million.
The insiders hold 7.45% of the company’s shares while institutions hold 38.98%. The data shows that short shares as of Feb 29, 2024, stood at 70720.0 at a short ratio of 0.23. This represents a 0.07% short interest in shares outstanding on Feb 29, 2024. Shares short fall in February from the previous month at 0.21 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 18.41% up in year-to-date price movement.
